Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rod Dunbar

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Cytotherapy|January 23, 2025
Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermisVaughan Feisst, Lisa Y Y Zhou, Chun-Jen Jennifer Chen, et al.
Plos Biology|February 18, 2004
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infectionLaura Papagno, Celsa A Spina, Arnaud Marchant, et al.
The Journal of Experimental Medicine|April 20, 2005
Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2017
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patientsOlivier Gasser, Katrina J Sharples, Catherine Barrow, et al.
Nature Medicine|April 3, 2002
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infectionsVictor Appay, P Rod Dunbar, Margaret Callan, et al.
Nature Communications|March 31, 2026
CXCR3 is associated with T-cell-induced heart damage in acute rheumatic feverFrancis M Middleton, Reuben McGregor, Natalie Lorenz, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infectionHarry L Janssen, Young-Suk Lim, Hyung Joon Kim, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2023
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanomaNathaniel Dasyam, Katrina J Sharples, Catherine Barrow, et al.
Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Cytotherapy|January 23, 2025
Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermisVaughan Feisst, Lisa Y Y Zhou, Chun-Jen Jennifer Chen, et al.
Plos Biology|February 18, 2004
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infectionLaura Papagno, Celsa A Spina, Arnaud Marchant, et al.
The Journal of Experimental Medicine|April 20, 2005
Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2017
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patientsOlivier Gasser, Katrina J Sharples, Catherine Barrow, et al.
Nature Medicine|April 3, 2002
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infectionsVictor Appay, P Rod Dunbar, Margaret Callan, et al.
Nature Communications|March 31, 2026
CXCR3 is associated with T-cell-induced heart damage in acute rheumatic feverFrancis M Middleton, Reuben McGregor, Natalie Lorenz, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infectionHarry L Janssen, Young-Suk Lim, Hyung Joon Kim, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2023
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanomaNathaniel Dasyam, Katrina J Sharples, Catherine Barrow, et al.
Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.
Pageof 10